BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20514474)

  • 1. Role of CDK8 and beta-catenin in colorectal adenocarcinoma.
    Seo JO; Han SI; Lim SC
    Oncol Rep; 2010 Jul; 24(1):285-91. PubMed ID: 20514474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of cyclin-dependent kinase 8 and β-catenin in the oncogenesis and progression of gastric adenocarcinoma.
    Kim MY; Han SI; Lim SC
    Int J Oncol; 2011 May; 38(5):1375-83. PubMed ID: 21344156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival.
    Firestein R; Shima K; Nosho K; Irahara N; Baba Y; Bojarski E; Giovannucci EL; Hahn WC; Fuchs CS; Ogino S
    Int J Cancer; 2010 Jun; 126(12):2863-73. PubMed ID: 19790197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganodermanontriol, a lanostanoid triterpene from Ganoderma lucidum, suppresses growth of colon cancer cells through ß-catenin signaling.
    Jedinak A; Thyagarajan-Sahu A; Jiang J; Sliva D
    Int J Oncol; 2011 Mar; 38(3):761-7. PubMed ID: 21225227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
    Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
    Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survival-stratification model of human colorectal carcinomas with beta-catenin and p27kip1.
    Cheah PY; Choo PH; Yao J; Eu KW; Seow-Choen F
    Cancer; 2002 Dec; 95(12):2479-86. PubMed ID: 12467060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDK8 regulates E2F1 transcriptional activity through S375 phosphorylation.
    Zhao J; Ramos R; Demma M
    Oncogene; 2013 Jul; 32(30):3520-30. PubMed ID: 22945643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas.
    Ozgüven BY; Karaçetin D; Kabukçuoğlu F; Taşkin T; Yener Ş
    Pol J Pathol; 2011; 62(1):19-24. PubMed ID: 21574102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of WNT pathway in surgically-treated colorectal cancer: β-catenin expression predicts for disease-free survival.
    Kamposioras K; Konstantara A; Kotoula V; Lakis S; Kouvatseas G; Akriviadis E; Vrettou E; Dionysopoulos D; Krikelis D; Papadopoulou K; Charalambous E; Chrisafi S; Konstantaras C; Fountzilas G
    Anticancer Res; 2013 Oct; 33(10):4573-84. PubMed ID: 24123033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Pin1 expression is associated with tumor progression in colorectal cancer.
    Kuramochi J; Arai T; Ikeda S; Kumagai J; Uetake H; Sugihara K
    J Surg Oncol; 2006 Aug; 94(2):155-60. PubMed ID: 16847925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic beta-catenin accumulation is a good prognostic marker in upper and lower gastrointestinal adenocarcinomas.
    Norwood MG; Bailey N; Nanji M; Gillies RS; Nicholson A; Ubhi S; Darnton JJ; Steyn RS; Womack C; Hughes A; Hemingway D; Harrison R; Waters R; Jankowski JA
    Histopathology; 2010 Jul; 57(1):101-11. PubMed ID: 20572881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive KL-6 mucin expression combined with decreased membranous beta-catenin expression indicates worse prognosis in colorectal carcinoma.
    Zhang W; Tang W; Inagaki Y; Qiu M; Xu HL; Li X; Sugawara Y; Nagawa H; Nakata M; Kokudo N
    Oncol Rep; 2008 Nov; 20(5):1013-9. PubMed ID: 18949395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wogonin induced G1 cell cycle arrest by regulating Wnt/β-catenin signaling pathway and inactivating CDK8 in human colorectal cancer carcinoma cells.
    He L; Lu N; Dai Q; Zhao Y; Zhao L; Wang H; Li Z; You Q; Guo Q
    Toxicology; 2013 Oct; 312():36-47. PubMed ID: 23907061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.
    Weichert W; Röske A; Niesporek S; Noske A; Buckendahl AC; Dietel M; Gekeler V; Boehm M; Beckers T; Denkert C
    Clin Cancer Res; 2008 Mar; 14(6):1669-77. PubMed ID: 18347167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transducers and activators of transcription 3 activation is involved in nuclear accumulation of beta-catenin in colorectal cancer.
    Kawada M; Seno H; Uenoyama Y; Sawabu T; Kanda N; Fukui H; Shimahara Y; Chiba T
    Cancer Res; 2006 Mar; 66(6):2913-7. PubMed ID: 16540637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancer.
    Horst D; Reu S; Kriegl L; Engel J; Kirchner T; Jung A
    Cancer; 2009 May; 115(10):2063-70. PubMed ID: 19298008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of FBXL20 in human colorectal adenocarcinoma.
    Zhu J; Li K; Dong L; Chen Y
    Oncol Rep; 2012 Dec; 28(6):2290-8. PubMed ID: 23023584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer.
    Boo YJ; Park JM; Kim J; Chae YS; Min BW; Um JW; Moon HY
    Ann Surg Oncol; 2007 May; 14(5):1703-11. PubMed ID: 17211730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity.
    Firestein R; Bass AJ; Kim SY; Dunn IF; Silver SJ; Guney I; Freed E; Ligon AH; Vena N; Ogino S; Chheda MG; Tamayo P; Finn S; Shrestha Y; Boehm JS; Jain S; Bojarski E; Mermel C; Barretina J; Chan JA; Baselga J; Tabernero J; Root DE; Fuchs CS; Loda M; Shivdasani RA; Meyerson M; Hahn WC
    Nature; 2008 Sep; 455(7212):547-51. PubMed ID: 18794900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.